Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

Brisbane breast cancer survivor Danique Hanson is making an emotional plea to Queenslanders: step up and volunteer for this ...

Baylor College of Medicine in Houston is at the forefront of advancements in breast cancer treatment by pioneering a "right-sizing surgery", potentially eliminating the need for surgery, chemotherapy, ...

Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a n ...

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...